Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
“Global Human Microbiome Therapeutics market set to grow to $1.6bn” by 2025 says new Visiongain report
The market for microbiome therapeutics is expected to commence around mid-2020 with the launch of new products relating to dermatology and gastrointestinal disorders.
04 December 2019
“Global Next-Generation Biologics market set to grow to $42bn by 2024” says new Visiongain report
Technological developments in the next-generation biologics market will be the result of clinical development of multiple platforms in the next-generation antibody, antibody fragment and ALP sectors.
04 December 2019
“Global Liquid Biopsy market set to grow to $4.9bn by 2024” says new Visiongain report
The main drivers for the growth include technological advancements such as development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.
04 December 2019
“Global nucleic acid isolation and purification market is anticipated to reach USD 8.16 Billion by 2030”, says Visiongain
Nucleic acid separation and purification is one of modern science and technology’s most complex and critical accomplishments.
29 November 2019
